DaVita Inc. 3rd Quarter 2017 Results
DaVita Inc. (NYSE: DVA) today announced results for the quarter ended September 30, 2017. Net loss attributable to DaVita Inc. for the quarter ended September 30, 2017 was $(214) million, or…
Uncategorized
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Uncategorized
DaVita Joins Patients in Urging Congress to Pass the Bipartisan Dialysis PATIENTS Demonstration Act
DaVita Kidney Care, a division of DaVita Inc., (NYSE: DVA), a leading independent provider of integrated health and kidney care services in the United States, today announced its strong support…
DaVita Boosts Efforts to Educate During National Diabetes Month
DaVita Inc. (NYSE: DVA), a leading independent medical group and a leading provider of kidney care services in the United States, joins the fight against diabetes by helping raise awareness during…
Integrated Care Improves Dialysis Patient Clinical Outcomes
DaVita Kidney Care, a division of DaVita Inc. (NYSE: DVA), a leading provider of kidney care services in the United States, today announced results of the first performance year in the Centers for…
The Everett Clinic Plays a Leading Role in Addressing Opioid Epidemic
The Everett Clinic, a DaVita Medical Group, division of DaVita Inc. (NYSE: DVA) and a leading independent medical group in the United States, received the Washington State Medical Association’s…